Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New directions for macrolide antibiotics: structural modifications and in vitro activity.

Literature DB >> 2684004

New directions for macrolide antibiotics: structural modifications and in vitro activity.

H A Kirst¹, G D Sides.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1989 PMID： 2684004 PMCID： PMC172675 DOI： 10.1128/AAC.33.9.1413

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

63 in total

1. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis.

Authors: F Daffos; F Forestier; M Capella-Pavlovsky; P Thulliez; C Aufrant; D Valenti; W L Cox
Journal: N Engl J Med Date: 1988-02-04 Impact factor: 91.245

2. Activity of macrolides against organisms responsible for respiratory infection with emphasis on Mycoplasma and Legionella.

Authors: K Hara; N Suyama; K Yamaguchi; S Kohno; A Saito
Journal: J Antimicrob Chemother Date: 1987-11 Impact factor: 5.790

3. The antimicrobial activity of A-56268 (TE-031) and roxithromycin (RU965) against Legionella using broth microdilution method.

Authors: R N Jones; A L Barry
Journal: J Antimicrob Chemother Date: 1987-06 Impact factor: 5.790

Review 4. Erythromycin.

Authors: D C Brittain
Journal: Med Clin North Am Date: 1987-11 Impact factor: 5.456

5. Erythromycin series. XII. Antibacterial in vitro evaluation of 10-dihydro-10-deoxo-11-azaerythromycin A: synthesis and structure-activity relationship of its acyl derivatives.

Authors: S Djokić; G Kobrehel; G Lazarevski
Journal: J Antibiot (Tokyo) Date: 1987-07 Impact factor: 2.649

6. Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicemia model.

Authors: P B Fernandes; D Hardy; R Bailer; E McDonald; J Pintar; N Ramer; R Swanson; E Gade
Journal: Antimicrob Agents Chemother Date: 1987-08 Impact factor: 5.191

7. Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria.

Authors: N X Chin; N M Neu; P Labthavikul; G Saha; H C Neu
Journal: Antimicrob Agents Chemother Date: 1987-03 Impact factor: 5.191

8. In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis.

Authors: W R Bowie; C E Shaw; D G Chan; W A Black
Journal: Antimicrob Agents Chemother Date: 1987-03 Impact factor: 5.191

9. In vitro susceptibility of Mycobacterium avium to a new macrolide (RU-28965).

Authors: M Casal; F Rodriguez; R Villalba
Journal: Chemotherapy Date: 1987 Impact factor: 2.544

10. Effects of rokitamycin and other macrolide antibiotics on Mycoplasma pneumoniae in L cells.

Authors: T Misu; S Arai; M Furukawa; Y Yamamoto; T Miyazaki
Journal: Antimicrob Agents Chemother Date: 1987-11 Impact factor: 5.191

43 in total

1. Effect of pH on radiometric MICs of clarithromycin against 18 species of mycobacteria.

Authors: N Rastogi; K S Goh
Journal: Antimicrob Agents Chemother Date: 1992-12 Impact factor: 5.191

Review 2. Formulary management of macrolide antibiotics.

Authors: D R Guay
Journal: Pharmacoeconomics Date: 1995-12 Impact factor: 4.981

3. Aerobic degradation of mercaptosuccinate by the gram-negative bacterium Variovorax paradoxus strain B4.

Authors: Irma Carbajal-Rodríguez; Nadine Stöveken; Barbara Satola; Jan Hendrik Wübbeler; Alexander Steinbüchel
Journal: J Bacteriol Date: 2010-11-12 Impact factor: 3.490

Review 4. Pharmacokinetics of newer drugs in patients with renal impairment (Part I).

Authors: J P Fillastre; E Singlas
Journal: Clin Pharmacokinet Date: 1991-04 Impact factor: 6.447

Review 5. Review of macrolides and ketolides: focus on respiratory tract infections.

Authors: G G Zhanel; M Dueck; D J Hoban; L M Vercaigne; J M Embil; A S Gin; J A Karlowsky
Journal: Drugs Date: 2001 Impact factor: 9.546

6. Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex.

Authors: N Rastogi; V Labrousse
Journal: Antimicrob Agents Chemother Date: 1991-03 Impact factor: 5.191

10. Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages.

Authors: D A Stamler; M A Edelstein; P H Edelstein
Journal: Antimicrob Agents Chemother Date: 1994-02 Impact factor: 5.191